Piramal CDMO begins solid oral dose production in the US

PPS has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Pennsylvania, US

picture of

Breaking News

New line for contract filling orders

Contract manufacturer SternMaid offers a diversity of equipment for filling products into different packs for the ...

Renibus chooses Cascade Chemistry for COVID-19 contract manufacturing

Cascade has been selected to produce the clincal trial API supplies for investigational therapy entering a Phase 2 ...

PCI and Experic announce strategic drug supply chain collaboration

Complementary technologies and capabilities add value and drive growth for both companies

Reducing time-to-market with innovative approaches to analytical services

The way in which drug developers approach analytical chemistry can be crucial in terms of driving efficiencies in ...

CordenPharma extends lipid excipients agreement with Moderna

The agreement has enabled CordenPharma to manufacture large-scale volumes of Moderna's lipid excipients to be used in ...

WuXi launches closed-process CAR-T cell therapy platform

CDMO WuXi Advanced Therapies has announced the expansion of its service capabilities to offer a fully integrated closed ...

Delivering certainty in uncertain times

Contract manufacturing organisations (CMOs) in the pharmaceutical sector operate at the sharp end of an industry in ...

Vibalogics to support Johnson & Johnson vaccine effort

The global CDMO that specialises in the production of virotherapy products has announced that it will manufacture ...

Quotient and CytoAgents accelerate treatment for COVID-19 cytokine storm

Collaboration expedites human clinical trials for COVID-19 drug candidate

Zenith on the buzzwords for pharma 2020

Joe Haugh, Zenith Technologies CEO, describes 2019 as a real watershed year, with topics such as Industry 4.0, ...

John Baker: life sciences need to address the reproducibility crisis

The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to ...

Integrated solutions offer fast-track development for biopharmaceuticals

At the heart of any successful medicine launch is a robust manufacturing process that will reliably make the product in ...

Merck invests $109m in viral vector and gene therapy manufacturing

German Merck has announced a second Carlsbad, California facility to double its BioReliance viral and gene therapy ...

Wavelength expands API supply for respiratory drugs in US and Europe

API supplier Wavelength Pharmaceuticals has also announced availability of its new CDMO services